Immunotherapy Study for Surgically Resected Pancreatic Cancer

Clinical trial NCT01072981 · COMPLETED

Trial details

NCT number: NCT01072981
Sponsor: NewLink Genetics Corporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2010-04-01
Primary completion: 2016-05-01
Enrollment: 722

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.